Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) in a note issued to investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Up 3.6 % Shares of CRBP stock opened at $5.50 on Monday. The business has a 50 […]

Related Keywords

,Dimensional Fund Advisors ,Renaissance Technologies ,News Ratings For Corbus Pharmaceuticals Daily ,Corbus Pharmaceuticals Stock ,Corbus Pharmaceuticals ,Vident Investment Advisory ,Corbus Pharmaceuticals Holdings Inc ,Hedge Funds Weigh In On Corbus Pharmaceuticals ,Get Free Report ,Sigma Investments ,Fund Advisors ,Investment Advisory ,Street Corp ,Pharmaceuticals Holdings ,Corbus Pharmaceuticals Daily ,Nasdaq Crbp ,Crbp ,Medical ,Initiated Coverage ,Stocknews Com ,